GSK Advances Blenrep’s Potential Comeback with Second Phase III Win

GSK Advances Blenrep’s Potential Comeback with Second Phase III Win

Submitted by admin on March 7, 2024 - 5:32pm
Source: 
BioSpace
News Tags: 
GSK
Blenrep
antibody-drug conjugate
clinial trials
Headline: 
GSK Advances Blenrep’s Potential Comeback with Second Phase III Win
snippet: 

GSK on Thursday reported a second Phase III win for its BCMA-directed antibody-drug conjugate Blenrep, boosting its prospects for getting the cancer drug back on the U.S. market.

Do Not Allow Advertisers to Use My Personal information